Literature DB >> 8441639

An anti-parallel triple helix motif with oligodeoxynucleotides containing 2'-deoxyguanosine and 7-deaza-2'-deoxyxanthosine.

J F Milligan1, S H Krawczyk, S Wadwani, M D Matteucci.   

Abstract

Triple helix formation of oligodeoxynucleotides (ODNs) with a 15 base pair poly-purine DNA target in the HER2 promoter was examined by footprinting analysis. 7-deaza-2'-deoxyxanthosine (dzaX) was identified as a purine analogue of thymidine (T) which forms dzaX:A-T triplets. ODNs containing 2'-deoxyguanosine (G) and dzaX were found to form triple helices in an anti-parallel orientation, with respect to the poly-purine strand of the target DNA. In comparative studies under physiological K+ and Mg++ concentrations and at pH 7.2, the ODNs containing G and dzaX showed high affinity to the target sequence while the ODNs containing G and T were not able to bind. In the absence of added monovalent salts both ODNs showed high affinity to the target sequence. The substitution of 7-deaza-2'-deoxyguanosine for G substantially decreased the capacity of the ODNs to form triple helices under physiological conditions, indicating that dzaX may be unique in its ability to enhance triple helix formation in the anti-parallel motif.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441639      PMCID: PMC309110          DOI: 10.1093/nar/21.2.327

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Solution structure of an unusually stable RNA tetraplex containing G- and U-quartet structures.

Authors:  C Cheong; P B Moore
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

2.  Monovalent cation-induced structure of telomeric DNA: the G-quartet model.

Authors:  J R Williamson; M K Raghuraman; T R Cech
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

3.  Palindromic octa- and dodecanucleotides containing 2'-deoxytubercidin: synthesis, hairpin formation, and recognition by the endodeoxyribonuclease EcoRI.

Authors:  F Seela; A Kehne
Journal:  Biochemistry       Date:  1987-04-21       Impact factor: 3.162

4.  Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.

Authors:  M Cooney; G Czernuszewicz; E H Postel; S J Flint; M E Hogan
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

5.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

6.  Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.

Authors:  M Tal; C R King; M H Kraus; A Ullrich; J Schlessinger; D Givol
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.

Authors:  L J Maher; B Wold; P B Dervan
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

8.  Synthesis of DNA via deoxynucleoside H-phosphonate intermediates.

Authors:  B C Froehler; P G Ng; M D Matteucci
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

9.  Models of triple-stranded polynucleotides with optimised stereochemistry.

Authors:  S Arnott; P J Bond; E Selsing; P J Smith
Journal:  Nucleic Acids Res       Date:  1976-10       Impact factor: 16.971

10.  Sequence-specific binding and photocrosslinking of alpha and beta oligodeoxynucleotides to the major groove of DNA via triple-helix formation.

Authors:  D Praseuth; L Perrouault; T Le Doan; M Chassignol; N Thuong; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  24 in total

1.  Targeting pyrimidine single strands by triplex formation: structural optimization of binding.

Authors:  T Vo; S Wang; E T Kool
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

2.  Oligodeoxynucleotides containing C-7 propyne analogs of 7-deaza-2'-deoxyguanosine and 7-deaza-2'-deoxyadenosine.

Authors:  C A Buhr; R W Wagner; D Grant; B C Froehler
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

3.  Sequence-specific targeting and covalent modification of human genomic DNA.

Authors:  E S Belousov; I A Afonina; M A Podyminogin; H B Gamper; M W Reed; R M Wydro; R B Meyer
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine.

Authors:  A F Faruqi; S H Krawczyk; M D Matteucci; P M Glazer
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

5.  Divalent transition metal cations counteract potassium-induced quadruplex assembly of oligo(dG) sequences.

Authors:  S W Blume; V Guarcello; W Zacharias; D M Miller
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

6.  Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.

Authors:  Faye A Rogers; Janice A Lloyd; Meetu Kaushik Tiwari
Journal:  Artif DNA PNA XNA       Date:  2014

7.  Overcoming potassium-mediated triplex inhibition.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

8.  Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides.

Authors:  M Musso; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

9.  Poly(L-lysine)-graft-dextran copolymer: amazing effects on triplex stabilization under physiological pH and ionic conditions (in vitro).

Authors:  A Ferdous; H Watanabe; T Akaike; A Maruyama
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

10.  Binding of DNA oligonucleotides to sequences in the promoter of the human bc1-2 gene.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.